By inhibiting replication, the large hepatitis delta antigen can indirectly regulate amber/W editing and its own expression

Journal of Virology

Volumn 78, Issue 15, 2004, Pages 8120-8134

  Sato, Shuji ^a   Cornillez Ty, Cromwell ^a   Lazinski, David W ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS DELTA ANTIGEN; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEIN HDAG L; PROTEIN HDAG S; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; HEPATITIS DELTA VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECONDARY STRUCTURE; PROTEIN SYNTHESIS; RNA EDITING; STOP CODON; VIRION; VIRUS ASSEMBLY; VIRUS INHIBITION; VIRUS REPLICATION;

CELLS, CULTURED; CODON; GENE EXPRESSION REGULATION, VIRAL; HEPATITIS DELTA ANTIGENS; HEPATITIS DELTA VIRUS; HUMANS; OPEN READING FRAMES; RNA EDITING; RNA, VIRAL; VIRUS REPLICATION;

EID: 3242688757     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.15.8120-8134.2004     Document Type: Article

References (38)

1. Bordier, B. B., P. L. Marion, K. Ohashi, M. A. Kay, H. B. Greenberg, J. L. Casey, and J. S. Glenn. 2002. A prenylation inhibitor prevents production of infectious hepatitis delta virus particles. J. Virol. 76:10465-10472.
2. Casey, J. L. 2002. RNA editing in hepatitis delta virus genotype III requires a branched double-hairpin RNA structure. J. Virol. 76:7385-7397.
3. Casey, J. L., K. F. Bergmann, T. L. Brown, and J. L. Gerin. 1992. Structural requirements for RNA editing in hepatitis delta virus: evidence for a uridine-to-cytidine editing mechanism. Proc. Natl. Acad. Sci. USA 89:7149-7153.
4. Casey, J. L., T. L. Brown, E. J. Colan, F. S. Wignall, and J. L. Gerin. 1993. A genotype of hepatitis D virus that occurs in northern South America. Proc. Natl. Acad. Sci. USA 90:9016-9020.
5. Casey, J. L., and J. L. Gerin. 1995. Hepatitis D virus RNA editing: specific modification of adenosine in the antigenomic RNA. J. Virol. 69:7593-7600.
6. Chang, F. L., P. J. Chen, S. J. Tu, C. J. Wang, and D. S. Chen. 1991. The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus. Proc. Natl. Acad. Sci. USA 88:8490-8494.
7. Chao, M., S. Y. Hsieh, and J. Taylor. 1990. Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication. J. Virol. 64:5066-5069.
8. Chen, P. J., G. Kalpana, J. Goldberg, W. Mason, B. Werner, J. Gerin, and J. Taylor. 1986. Structure and replication of the genome of the hepatitis delta virus. Proc. Natl. Acad. Sci. USA 83:8774-8778.
9. Cheng, Q., G. C. Jayan, and J. L. Casey. 2003. Differential inhibition of RNA editing in hepatitis delta virus genotype III by the short and long forms of hepatitis delta antigen. J. Virol. 77:7786-7795.
10. Glenn, J. S., J. C. Marsters, Jr., and H. B. Greenberg. 1998. Use of a prenylation inhibitor as a novel antiviral agent. J. Virol. 72:9303-9306.
11. Glenn, J. S., J. Taylor, and J. M. White. 1991. Replication of monomeric genomic delta RNA in cultured cells. Prog. Clin. Biol. Res. 364:293-297.
12. Glenn, J. S., and J. M. White. 1991. trans-dominant inhibition of human hepatitis delta virus genome replication. J. Virol. 65:2357-2361.
13. Govindarajan, S., S. Hwang, and M. M. Lai. 1993. Comparison of the presence of two forms of delta antigen in liver tissues of acute versus chronic delta hepatitis. Prog. Clin. Biol. Res. 382:139-143.
14. Hsieh, S. Y., M. Chao, L. Coates, and J. Taylor. 1990. Hepatitis delta virus genome replication: a polyadenylated mRNA for delta antigen. J. Virol. 64:3192-3198.
15. Hwang, S. B., and M. M. Lai. 1994. Isoprenylation masks a conformational epitope and enhances trans-dominant inhibitory function of the large hepatitis delta antigen. J. Virol. 68:2958-2964.
16. Jayan, G. C., and J. L. Casey. 2002. Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2. J. Virol. 76:3819-3827.
17. Jayan, G. C., and J. L. Casey. 2002. Inhibition of hepatitis delta virus RNA editing by short inhibitory RNA-mediated knockdown of ADAR1 but not ADAR2 expression. J. Virol. 76:12399-12404.
18. Kuo, M. Y., M. Chao, and J. Taylor. 1989. Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J. Virol. 63:1945-1950.
19. Kuo, M. Y., J. Goldberg, L. Coates, W. Mason, J. Gerin, and J. Taylor. 1988. Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications. J. Virol. 62:1855-1861.
20. Kuo, M. Y., L. Sharmeen, G. Dinter-Gottlieb, and J. Taylor. 1988. Characterization of self-cleaving RNA sequences on the genome and antigenome of human hepatitis delta virus. J. Virol. 62:4439-4444.
21. Lazinski, D. W., and J. M. Taylor. 1994. Expression of hepatitis delta virus RNA deletions: cis and trans requirements for self-cleavage, ligation, and RNA packaging. J. Virol. 68:2879-2888.
22. Lazinski, D. W., and J. M. Taylor. 1995. Intracellular cleavage and ligation of hepatitis delta virus genomic RNA: regulation of ribozyme activity by cis-acting sequences and host factors. J. Virol. 69:1190-1200.
23. Lazinski, D. W., and J. M. Taylor. 1993. Relating structure to function in the hepatitis delta virus antigen. J. Virol. 67:2672-2680.
24. Luo, G. X., M. Chao, S. Y. Hsieh, C. Sureau, K. Nishikura, and J. Taylor. 1990. A specific base transition occurs on replicating hepatitis delta virus RNA. J. Virol. 64:1021-1027.
25. Maas, S., S. Patt, M. Schrey, and A. Rich. 2001. Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc. Natl. Acad. Sci. USA 98:14687-14692.
26. Macnaughton, T. B., and M. M. Lai. 2002. Large hepatitis delta antigen is not a suppressor of hepatitis delta virus RNA synthesis once RNA replication is established. J. Virol. 76:9910-9919.
27. Modahl, L. E., and M. M. Lai. 2000. The large delta antigen of hepatitis delta virus potently inhibits genomic but not antigenomic RNA synthesis: a mechanism enabling initiation of viral replication. J. Virol. 74:7375-7380.
28. Polson, A. G., H. L. Ley III, B. L. Bass, and J. L. Casey. 1998. Hepatitis delta virus RNA editing is highly specific for the amber/W site and is suppressed by hepatitis delta antigen. Mol. Cell. Biol. 18:1919-1926.
29. Reid, C. E., and D. W. Lazinski. 2000. A host-specific function is required for ligation of a wide variety of ribozyme-processed RNAs. Proc. Natl. Acad. Sci. USA 97:424-429.
30. Rizzetto, M., M. G. Canese, J. L. Gerin, W. T. London, D. L. Sly, and R. H. Purcell. 1980. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J. Infect. Dis. 141:590-602.
31. Ryu, W. S., H. J. Netter, M. Bayer, and J. Taylor. 1993. Ribonucleoprotein complexes of hepatitis delta virus. J. Virol. 67:3281-3287.
32. Sato, S., S. K. Wong, and D. W. Lazinski. 2001. Hepatitis delta virus minimal substrates competent for editing by ADAR1 and ADAR2. J. Virol. 75:8547-8555.
33. Shakil, A. O., S. Hadziyannis, J. H. Hoofnagle, A. M. Di Bisceglie, J. L. Gerin, and J. L. Casey. 1997. Geographic distribution and genetic variability of hepatitis delta virus genotype I. Virology 234:160-167.
34. Sharmeen, L., M. Y. Kuo, G. Dinter-Gottlieb, and J. Taylor. 1988. Antigenomic RNA of human hepatitis delta virus can undergo self-cleavage. J. Virol. 62:2674-2679.
35. Wong, S. K., and D. W. Lazinski. 2002. Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1. Proc. Natl. Acad. Sci. USA 99:15118-15123.
36. Wong, S. K., S. Sato, and D. W. Lazinski. 2003. Elevated activity of the large form of ADAR1 in vivo: very efficient RNA editing occurs in the cytoplasm. RNA 9:586-598.
37. Wong, S. K., S. Sato, and D. W. Lazinski. 2001. Substrate recognition by ADAR1 and ADAR2. RNA 7:846-858.
38. Wu, T. T., V. V. Bichko, W. S. Ryu, S. M. Lemon, and J. M. Taylor. 1995. Hepatitis delta virus mutant: effect on RNA editing. J. Virol. 69:7226-7231.